mevalonolactone has been researched along with farnesyl pyrophosphate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dull, BJ; Kilara, A; McCarthy, RD | 1 |
| Jacobsen, LL; Johansen, HT; Rustan, AC; Smith, R; Solberg, R; Thoresen, GH; Voreland, AL | 1 |
2 other study(ies) available for mevalonolactone and farnesyl pyrophosphate
| Article | Year |
|---|---|
The modulating effect of an inhibitor of cholesterolgenesis present in bovine milk upon the synthesis of cholesterol, dolichol and ubiquinone.
Topics: Acetates; Acetic Acid; Animals; Anticholesteremic Agents; Cattle; Cholesterol; Cholesterol, LDL; Diterpenes; Dolichols; In Vitro Techniques; Lanosterol; Lipoproteins, LDL; Liver; Mevalonic Acid; Milk; Orotic Acid; Polyisoprenyl Phosphates; Rats; Sesquiterpenes; Squalene; Ubiquinone | 1983 |
Simvastatin inhibits glucose metabolism and legumain activity in human myotubes.
Topics: Cathepsin B; Cathepsin L; Cell Membrane; Cysteine Endopeptidases; Glucose; HEK293 Cells; Humans; Mevalonic Acid; Muscle Fibers, Skeletal; Oxidation-Reduction; Oxidative Phosphorylation; Polyisoprenyl Phosphates; Sesquiterpenes; Simvastatin | 2014 |